129 related articles for article (PubMed ID: 3551524)
1. The effect of copper ions in vivo on specific hormonal endometrial receptors.
de Castro A; Gonzalez-Gancedo P; Contreras F; Lapeña G
Adv Contracept; 1986 Dec; 2(4):399-404. PubMed ID: 3551524
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of high-load copper IUDs.
de Castro A; Gonzalez-Gancedo P
Adv Contracept; 1988 Sep; 4(3):185-90. PubMed ID: 3239479
[TBL] [Abstract][Full Text] [Related]
3. Histological reactions of human endometrium to the IUD.
de Castro A; Contreras F
Adv Contracept; 1988 Sep; 4(3):191-5. PubMed ID: 3239480
[TBL] [Abstract][Full Text] [Related]
4. Endometrial estrogen and progestin receptors in women bearing a progesterone-releasing intrauterine device.
Jänne O; Ylöstalo P
Contraception; 1980 Jul; 22(1):19-23. PubMed ID: 7418404
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?
Guleria K; Agarwal N; Mishra K; Gulati R; Mehendiratta A
J Obstet Gynaecol Res; 2004 Jun; 30(3):181-7. PubMed ID: 15210039
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of three copper IUDs (MLCu250, MLCu375 and Nova-T).
Bratt H; Skjeldestad FE; Cullberg Valentin K
Acta Obstet Gynecol Scand; 1988; 67(3):247-51. PubMed ID: 3051876
[TBL] [Abstract][Full Text] [Related]
7. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
9. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium.
Ammälä M; Nyman T; Strengell L; Rutanen EM
Fertil Steril; 1995 Apr; 63(4):773-8. PubMed ID: 7890061
[TBL] [Abstract][Full Text] [Related]
10. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
11. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
12. Hormonal intrauterine devices.
Rybo G; Andersson K; Odlind V
Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
[TBL] [Abstract][Full Text] [Related]
13. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
Wang IY; Russell P; Fraser IS
Contraception; 1995 Apr; 51(4):243-8. PubMed ID: 7796590
[TBL] [Abstract][Full Text] [Related]
14. The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use.
Zhu P; Liu X; Luo H; Gu Z; Cheng J; Xu R; Lian S; Wu S; Wang J
Hum Reprod; 1999 Apr; 14(4):970-5. PubMed ID: 10221229
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of action of the copper intrauterine device.
Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
[TBL] [Abstract][Full Text] [Related]
16. Endometrial morphological changes in IUD users: a review.
Sheppard BL
Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
[TBL] [Abstract][Full Text] [Related]
17. Endometrial contraception: modulation of molecular determinants of uterine receptivity.
Puri CP; Katkam RR; Sachdeva G; Patil V; Manjramkar DD; Kholkute SD
Steroids; 2000; 65(10-11):783-94. PubMed ID: 11108889
[TBL] [Abstract][Full Text] [Related]
18. Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device.
Nilsson CG; Luukkainen T; Diaz J; Allonen H
Contraception; 1982 Apr; 25(4):345-56. PubMed ID: 6809420
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
[TBL] [Abstract][Full Text] [Related]
20. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
Umapathysivam K; Jones WR
Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
